Loading…
Pharmacogenomics of cisplatin-based chemotherapy in ovarian-cancer patients from Yakutia
A DNA polymorphism is one of the most important factors determining individual variations in patients’ responses to the same medicinal preparations. This work deals with assessment of associations between polymorphisms of 106 genes involved in key processes of cellular activity (xenobiotic metabolis...
Saved in:
Published in: | Molecular genetics, microbiology and virology microbiology and virology, 2013-10, Vol.28 (4), p.137-140 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | A DNA polymorphism is one of the most important factors determining individual variations in patients’ responses to the same medicinal preparations. This work deals with assessment of associations between polymorphisms of 106 genes involved in key processes of cellular activity (xenobiotic metabolism, DNA repair, the cell cycle, and the regulation of apoptosis) and the outcomes of a cisplatin-based chemotherapy in a cohort of ovarian-cancer patients from Yakutia. The
CDKN1B
gene polymorphism (rs34330) has been found to be associated with the frequency of complete remissions. The allelic status of this locus was also shown to be significant for progression-free survival. The allelic status at the
EPXH1
gene loci (rs2234922 and rs2260863) correlated with impairments in hearing, while the
NBN
gene polymorphism (rs1063045) was associated with severe emesis. |
---|---|
ISSN: | 0891-4168 1934-841X |
DOI: | 10.3103/S0891416813040034 |